PMDA drug package insert
ヒポカ5mgカプセル
PMDA Prescription drug · LTLファーマ株式会社 · package insert Jul 21, 2026
Key facts
| Brand names | ヒポカ5mgカプセル, ヒポカ10mgカプセル, ヒポカ15mgカプセル |
|---|---|
| Nonproprietary names | バルニジピン塩酸塩 |
| Companies | 製造販売／LTLファーマ株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 持効性Ca拮抗剤 |
| Therapeutic category codes | 872149 |
| YJ codes | 2149030N1027, 2149030N2023, 2149030N3020 |
| Approval numbers | 20400AMZ00889, 20400AMZ00890, 20400AMZ00891 |
| Package insert edition | 第3版 |
| Package insert date | Jul 21, 2026 |
| PMDA document key | 171911_2149030N1027_2 |
| PMDA company code | 171911 |
At a glance
- 1–9 Package insert revisions
- 1–9 Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: